1) Cerutti, M.

Rescigno, The biology of intestinal immunoglobulin A responses, Immunity 28

(2008) 740–750.
2) K. Singh, C. Chang, M.E. Gershwin, IgA deficiency and autoimmunity, Autoimmun. Rev. 13
(2014) 163–177.
3) C.R. Jolliff, K.M. Cost, P.C. Stivrins, P.P. Grossman, C.R. Nolte, S.M. Franco, et al., Reference
intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry, Clin. Chem.
28 (1982) 126–128.
4) European Society for Immunodeficiencies, ESID Registry–Working definitions for clinical
diagnosis of PID, 2019, Jan 22. https://esid.org/working-parties/registryworking-party-diagnosis-
criteria.
5) S. Saghafi, Z. Pourpak, A. Aghamohammadi, A.A. Pourfathollah, A. Samadian, M. Farghadan,
et al., Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory
and clinical findings, Iran. J. Allergy, Asthma Immunol. 7 (2008) 157–162.
6) Patel SY, Carbone J, Jolles S (2019): The Expanding Field of Secondary Antibody Deficiency:
Causes, Diagnosis, and Management. Front Immunol 10: 33.
7) Na I-K, Buckland M, Agostini C, et al. (2019): Current clinical practice and challenges in the
management of secondary immunodeficiency in hematological malignancies. Eur J Haematol
102: 447-456.
8) Benbrahim O, Viallard JF, Choquet S, et al. (2019): The use of octagam and gammanorm in
immunodeficiency associated with hematological malignancies: a prospective study from 21
French hematology departments. Hematology 24: 173182.
9) Jahnz-Rozyk K, Roliński J, Siedlar M, et al. (2019): Secondary immunodeficiencies – do we
need systemic solutions. JHPOR 1: 2299124.
10) Patel SY, Carbone J, Jolles S (2019): The Expanding Field of Secondary Antibody Deficiency:
Causes, Diagnosis, and Management. Front Immunol 10: 33.
11) Na I-K, Buckland M, Agostini C, et al. (2019): Current clini- cal practice and challenges in the
management of secondary immunodeficiency in hematological malignancies. Eur J Haematol
102: 447-456.
12) Korzeniowska M, Więsik-Szewczyk E, Jahnz-Różyk K (2018): Opis przypadku chorego na
przewlekłą białaczkę limfocytową i ciężkie zapalenie płuc – jak nie przeoczyć wtórnego
niedoboru przeciwciał. [Case report of a patient with chronic lymphocytic leukemia and severe
pneumonia – how not to miss a secondary antibody deficiency]. Alergologia i Immunologia
Współczesna 41: 35-41.
13) Jahnz-Rozyk K, Roliński J, Siedlar M, et al. (2019): Secondary immunodeficiencies – do we
need systemic solutions. JHPOR 1: 2299124, https://www.gov.pl/web/zdrowie/programy-lekowe
14) Dhalla F, Misbah SA (2015): Secondary antibody deficiency. Curr Opin Allergy Clin Immunol
15: 505-513.
15) Morrison VA (2010): Infectious complications of chronic lymphocytic leukaemia: pathogenesis,
spectrum of infection, preventive approaches. Best Pract Res Clin Haematol 23: 145153.
16) L. Mellemkjaer, L. Hammarstrom, V. Andersen, J. Yuen, C. Heilmann, T. Barington, et al.,
Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their
relatives: a combined Danish and Swedish study, Clin. Exp. Immunol. 130 (2002) 495–500.
17) T. Cheraghi, A. Aghamohammadi, B. Mirminachi, T. Keihanian, E. Hedayat, H. Abolhassani, et
al., Prediction of the evolution of common variable immunodeficiency: HLA typing for patients
with selective IgA deficiency, J Investig.
18) Puck JM. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia.
Immunol Rev. 2019;287(1):241–252.
19) Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of
primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5). 1186205.e1-78.
20) McAtee CL, Lubega J, Underbrink K, et al. Association of rituximab use with adverse events in
children, adolescents, and young adults. JAMA Netw Open. 2021;4(2): e2036321
21) Strehl C, Ehlers L, Gaber T, Buttgereit F. Glucocorticoids-all-rounders tackling the versatile
players of the immune system. Front Immunol. 2019;10: 1744.
22) Lodish MB, Keil MF, Stratakis CA. Cushing’s syndrome in pediatrics: an update. Endocrinol
Metab Clin North Am. 2018;47(2):451–462.
23) Engel ER, Walter JE. Rituximab and eculizumab when treating nonmalignant hematologic
disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs.
Hematology Am Soc Hematol Educ Program. 2020;1 (1):312–318.
24) McAtee CL, Lubega J, Underbrink K, et al. Association of rituximab use with adverse events in
children, adolescents, and young adults. JAMA Netw Open. 2021;4(2): e2036321.
25) Ottaviano G, Marinoni M, Graziani S, et al. Rituximab unveils hypogammaglobulinemia and
immunodeficiency in children with autoimmune cytopenia. J Allergy Clin Immunol Pract.
2020;8(1):273–282.
26) Calabrese C, Winthrop KL. Mycobacterial infections potentiated by biologics. Infect Dis Clin
North Am. 2020;34(2):413–423.
27) Kaptan Y, Suner A, Tas¸ MN, Oksel F, Aksu K, Sayiner A. Tuberculosis despite latent infection
screening and treatment in patients receiving TNF inhibitor therapy. Clin Rheumatol.
2021;40(9):3783–3788.
28) Eom TH, Lee HS, Jang PS, Kim YH. Valproate-induced panhypogammaglobulinemia. Neurol
Sci. 2013;34(6):1003–1004
29) M.M. Carneiro-Sampaio, S.B. Carbonare, R.B. Rozentraub, M.N. de Araujo, M.A. Riberiro,
M.H. Porto, Frequency of selective IgA deficiency among Brazilian blood donors and healthy
pregnant women, Allergol. Immunopathol. 17 (1989) 213–216.
30) L.F. Pereira, A.M. Sapina, J. Arroyo, J. Vinuelas, R.M. Bardaji, L. Prieto, Prevalence of
selective IgA deficiency in Spain: more than we thought, Blood 90 (1997) 893.
31) L. Feng, [Epidemiological study of selective IgA deficiency among 6 nationalities in China],
Zhonghua Yixue Zazhi 72 (1992), 88-90, 128.
32) T. Kanoh, T. Mizumoto, N. Yasuda, M. Koya, Y. Ohno, H. Uchino, et al., Selective IgA
deficiency in Japanese blood donors: frequency and statistical analysis, Vox Sanguinis 50 (1986)
81–86.
33) N. Wang, P. Lu, B. Ling, Z. Zhu, L. Hammarstrom, Caucasian origin of disease associated HLA
haplotypes in Chinese blood donors with IgA deficiency, J. Clin.Immunol. 34 (2014) 157–162.
34) J. Koistinen, Familial clustering of selective IgA deficiency, Vox Sanguinis 30 (1976) 181–190
35) M. Frankowiack, R.M. Kovanen, G.A. Repasky, C.K. Lim, C. Song, N.L. Pedersen, et al., The
higher frequency of IgA deficiency among Swedish twins is not explained by HLA haplotypes,
Genes Immun. 16 (2015) 199–205.
36) R. Yazdani, G. Azizi, H. Abolhassani, A. Aghamohammadi, Selective IgA deficiency:
37) epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management, Scand. J.
Immunol. 85 (2017) 3–12.
38) M.E. Conley, M.D. Cooper, Immature IgA B cells in IgA-deficient patients, N. Engl. J. Med. 305
(1981) 495–497.
39) L. Hammarstrom, B. Lonnqvist, O. Ringden, C.I. Smith, T. Wiebe, Transfer of IgA deficiency to
a bone-marrow-grafted patient with aplastic anaemia, Lancet 1 (1985) 778–781.
40) Cunningham-Rundles, Physiology of IgA and IgA deficiency, J. Clin. Immunol. 21 (2001) 303–
309.
41) A.J. Ramsay, A.J. Husband, I.A. Ramshaw, S. Bao, K.I. Matthaei, G. Koehler, et al., The role of
interleukin-6 in mucosal IgA antibody responses in vivo, Science 264 (1994) 561–563.
42) S. Borte, Q. Pan-Hammarstrom, C. Liu, U. Sack, M. Borte, U. Wagner, et al., Interleukin-21
restores immunoglobulin production ex vivo in patients with common variable immunode
ficiency and selective IgA deficiency, Blood 114 (2009) 4089– 4098.
43) A. Cerutti, The regulation of IgA class switching, Nat. Rev. Immunol. 8 (2008) 421– 434.
44) H. Soheili, H. Abolhassani, N. Arandi, H.A. Khazaei, S. Shahinpour, A. HirbodMobarakeh, et
al., Evaluation of natural regulatory T cells in subjects with selective IgA de ficiency: from
senior idea to novel opportunities, Int. Arch. Allergy Immunol. 160 (2013) 208– 214.
45) H. Tezuka, T. Ohteki, Regulation of IgA production by intestinal dendritic cells and related cells,
Front. Immunol. 10 (2019) 1– 15.
46) J. Ortiz, M. Fernandez-Arquero, E. Urcelay, R. Lopez-Mejias, A. Ferreira, G. Fontan, et al.,
Interleukin-10 polymorphisms in Spanish IgA de ficiency patients: a casecontrol and family
study, BMC Med. Genet. 7 (2006) 56.
47) F.A. Bonilla, D.A. Khan, Z.K. Ballas, J. Chinen, M.M. Frank, J.T. Hsu, et al., Practice parameter
for the diagnosis and management of primary immunodeficiency, J. Allergy Clin. Immunol. 136
(2015) 1186–1205, e1-78.
48) R. Yazdani, G. Azizi, H. Abolhassani, A. Aghamohammadi, Selective IgA deficiency:
epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management, Scand. J.
Immunol. 85 (2017) 3–12.European Society for Immunodeficiencies, Differential Diagnosis of
Hypogammaglobulinemia, 2018. https://ESID.org/education
49) O.H. Robak, M.M. Helmesaat, A.A. Kruglov, S. Prepens, J. Ninnemann, B. Gutbier, et al.,
Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas
aeruginosa pneumonia, J. Clin. Investig. 128 (2018) 3535–3545.
50) E.A. Murphy, A.J. Morris, E. Walker, F.D. Lee, R.D. Sturrock, Cyclosporine A induced colitis
and acquired selective IgA deficiency in a patient with juvenile chronic arthritis, J. Rheumatol.
20 (1993) 1397–1398.
51) K. Singh, C. Chang, M.E. Gershwin, IgA deficiency and autoimmunity, Autoimmun. Rev. 13
(2014) 163–177.
52) R. Yazdani, A. Latif, F. Tabassomi, H. Abolhassani, G. Aziz, N. Rezaei, et al., Clinical
phenotype classification for selective immunoglobulin A deficiency, Expert Rev.Clin. Immunol.
11 (2015) 1245–1254.
53) P. Brandtzaeg, G. Karlsson, G. Hansson, B. Petruson, J. Bjorkander, L.A. Hanson, The clinical
condition of IgA-deficient patients is related to the proportion of IgDand IgM-producing cells in
their nasal mucosa, Clin. Exp. Immunol. 67 (1987) 626–636.
54) S.G. Sandler, D. Mallory, D. Malamut, R. Eckrich, IgA anaphylactic transfusion reactions,
Transfus. Med. Rev. 9 (1995) 1–8.
55) C.J. Ocampo, A.T. Peters, Antibody deficiency in chronic rhinosinusitis: epidemiology and
burden of illness, Am. J. Rhinol. Allergy 27 (2013) 34–38.
56) Cunningham-Rundles, Physiology of IgA and IgA deficiency, J. Clin. Immunol. 21 (2001) 303–
309.
57) F.A. Bonilla, D.A. Khan, Z.K. Ballas, J. Chinen, M.M. Frank, J.T. Hsu, et al., Practice parameter
for the diagnosis and management of primary immunodeficiency, J. Allergy Clin. Immunol. 136
(2015) 1186–1205, e1-78.
58) M. Janzi, I. Kull, R. Sjoberg, J. Wan, E. Melen, N. Bayat, et al., Selective IgA deficiency in early
life: association to infections and allergic diseases during childhood, Clin. Immunol. 133 (2009)
78–85.
59) Edwards, S. Razvi, C. Cunningham-Rundles, IgA deficiency: clinical correlates and responses to
pneumococcal vaccine, Clin. Immunol. 111 (2004) 93–97.
60) M.A. French, K.A. Denis, R. Dawkins, J.B. Peter, Severity of infections in IgA deficiency:
correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased
serum IgG2 and/or IgG4, Clin. Exp. Immunol. 100 (1995) 47–53.
61) H. Ozkan, F. Atlihan, F. Genel, S. Targan, T. Gunvar, IgA and/or IgG subclass deficiency in
children with recurrent respiratory infections and its relationship with chronic pulmonary
damage, J Investig. Allergol. Clin. Immunol. 15 (2005) 69–74.
62) G.H. Jorgensen, A. Gardulf, M.I. Sigurdsson, S.T. Sigurdardottir, I. Thorsteinsdottir, S.
Gudmundsson, et al., Clinical symptoms in adults with selective IgA deficiency: a case-control
study, J. Clin. Immunol. 33 (2013) 742–747.
63) Edwards, S. Razvi, C. Cunningham-Rundles, IgA deficiency: clinical correlates and responses to
pneumococcal vaccine, Clin. Immunol. 111 (2004) 93–97.
64) B.E. Chipps, R.C. Talamo, J.A. Winkelstein, IgA deficiency, recurrent pneumonias, and
bronchiectasis, Chest 73 (1978) 519–526.
65) S. Albin, C. Cunningham-Rundles, An update on the use of immunoglobulin for the treatment of
immunodeficiency disorders, Immunotherapy 6 (2014) 1113–1126.
66) S. Zielen, I. Buhring, N. Strnad, J. Reichenbach, D. Hofmann, Immunogenicity and tolerance of
a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23valent pneumococcal
vaccine, Infect. Immun. 68 (2000) 1435–1440.
67) F.A. Bonilla, D.A. Khan, Z.K. Ballas, J. Chinen, M.M. Frank, J.T. Hsu, et al., Practice parameter
for the diagnosis and management of primary immunodeficiency, J. Allergy Clin. Immunol. 136
(2015) 1186–1205, e1-78.
68) H.H. Zinneman, A.P. Kaplan, The association of giardiasis with reduced intestinal secretory
immunoglobulin A, Am. J. Dig. Dis. 17 (1972) 793–797.
69) S. Agarwal, L. Mayer, Pathogenesis and treatment of gastrointestinal disease in antibody
deficiency syndromes, J. Allergy Clin. Immunol. 124 (2009) 658–664.
70) Norhagen, P.E. Engstrom, L. Hammarstrom, P.O. Soder, C.I. Smith, Immunoglobulin levels in
saliva in individuals with selective IgA deficiency: compensatory IgM secretion and its
correlation with HLA and susceptibility to infections, J. Clin. Immunol. 9 (1989) 279–286.
71) C. Istrate, J. Hinkula, L. Hammarstrom, L. Svensson, Individuals with selective IgA deficiency
resolve rotavirus disease and develop higher antibody titers (IgG, IgG1) than IgA competent
individuals, J. Med. Virol. 80 (2008) 531–535.
72) M. Janzi, I. Kull, R. Sjoberg, J. Wan, E. Melen, N. Bayat, et al., Selective IgA deficiency in early
life: association to infections and allergic diseases during childhood, Clin. Immunol. 133 (2009)
78–85.
A. Aghamohammadi, T. Cheraghi, M. Gharagozlou, M. Movahedi, N. Rezaei, M. Yeganeh, et al.,
IgA deficiency: correlation between clinical and immunological phenotypes, J. Clin. Immunol.
29 (2009) 130–136.
73) E. Edwards, S. Razvi, C. Cunningham-Rundles, IgA deficiency: clinical correlates and responses
to pneumococcal vaccine, Clin. Immunol. 111 (2004) 93–97.
74) A. Franco, R. Parrella, F. Murru, P.R. Ames, F. Martucci, G. Rotiroti, et al., Lack of association
between IgA deficiency and respiratory atopy in young male adults, Vivo 25 (2011) 829–832.
75) G.H. Jorgensen, A. Gardulf, M.I. Sigurdsson, S.T. Sigurdardottir, I. Thorsteinsdottir, S.
Gudmundsson, et al., Clinical symptoms in adults with selective IgA deficiency: a case-control
study, J. Clin. Immunol. 33 (2013) 742–747.
76) C. Cunningham-Rundles, Physiology of IgA and IgA deficiency, J. Clin. Immunol. 21 (2001)
303–309.
77) Abolhassani, B. Gharib, S. Shahinpour, S.N. Masoom, A. Havaei, B. Mirminachi, et al.,
Autoimmunity in patients with selective IgA deficiency, J Investig. Allergol.Clin. Immunol. 25
(2015) 112–119.
78) K. Singh, C. Chang, M.E. Gershwin, IgA deficiency and autoimmunity, Autoimmun. Rev. 13
(2014) 163–177
79) C. Cunningham-Rundles, W.E. Brandeis, D.J. Pudifin, N.K. Day, R.A. Good, Autoimmunity in
selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune
complexes and clinical disease, Clin. Exp. Immunol.45 (1981) 299–304.
80) J. Mohammadi, R. Ramanujam, S. Jarefors, N. Rezaei, A. Aghamohammadi, P.K. Gregersen, et
al., IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the
HLA A1 B8, DR3 (8.1) haplotype, J. Clin. Immunol.30 (2010) 138–143.
81) Soheili, H. Abolhassani, N. Arandi, H.A. Khazaei, S. Shahinpour, A. HirbodMobarakeh, et al.,
Evaluation of natural regulatory T cells in subjects with selective IgA de ficiency: from senior
idea to novel opportunities, Int. Arch. Allergy Immunol. 160 (2013) 208– 214.
82) E. Gianchecchi, D.V. Delfino, A. Fierabracci, NK cells in autoimmune diseases: linking innate
and adaptive immune responses, Autoimmun. Rev. 17 (2018) 142–154.
83) M. Cattalini, M. Soliani, M.C. Caparello, R. Cimaz, Sex differences in pediatric rheumatology,
Clin. Rev. Allergy Immunol. 56 (2019) 293–307.
84) R.C. Ferreira, Q. Pan-Hammarstrom, R.R. Graham, V. Gateva, G. Fontan, A.T. Lee, et al.,
Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency, Nat.
Genet. 42 (2010) 777–780.
85) R.C. Ferreira, Q. Pan-Hammarstrom, R.R. Graham, V. Gateva, G. Fontan, A.T. Lee, et al.,
Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency, Nat.
Genet. 42 (2010) 777–780.
86) M.A. Heneghan, F.M. Stevens, E.M. Cryn, et al., Celiac sprue and immunodeficiency states: a
25 year review, J. Clin. Gasteroentrol 25 (1997) 421–425.
87) V. Lougaris, A. Sorlini, C. Monfredini, G. Ingrasciotta, A. Caravaggio, T. Lorenzini, et al.,
Clinical and laboratory features of 184 Italian pediatric patients affected with selective IgA
deficiency (SIgAD): a longitudinal single-center study, J. Clin.Immunol. 39 (2019) 470–475.
88) R. Yazdani, G. Azizi, H. Abolhassani, A. Aghamohammadi, Selective IgA deficiency:
89) epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management, Scand. J.
Immunol. 85 (2017) 3–12.
90) M.A. Chow, B. Lebwohl, N.R. Reilly, P.H. Green, Immunoglobulin A deficiency in celiac
disease, J. Clin. Gastroenterol. 46 (2012) 850–854.
91) 1.Yazdani R, Azizi G, Abolhassani H, Aghamohammadi A. Selective IgA Deficiency:
Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scand
J Immunol. 2017 Jan;85(1):3-12. [PubMed]
92) Mertin S, Thomson I. What you need to know about IgA deficiency: a case study. J Am Assoc
Nurse Pract. 2014 May;26(5):268-72. [PubMed]
93) Patel SY, Carbone J, Jolles S. The Expanding Field of Secondary Antibody Deficiency: Causes,
Diagnosis, and Management. Front Immunol. 2019;10:33. [PMC free article] [PubMed]
94) Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmun Rev. 2014
Feb;13(2):163-77. [PubMed]
95) Murphy EA, Morris AJ, Walker E, Lee FD, Sturrock RD. Cyclosporine A induced colitis and
acquired selective IgA deficiency in a patient with juvenile chronic arthritis. J Rheumatol. 1993
Aug;20(8):1397-8. [PubMed]
96) Aarli JA. Drug-induced IgA deficiency in epileptic patients. Arch Neurol. 1976 Apr;33(4):296-9.
[PubMed]
97) Snowden N, Dietch DM, Teh LS, Hilton RC, Haeney MR. Antibody deficiency associated with
gold treatment: natural history and management in 22 patients. Ann Rheum Dis. 1996
Sep;55(9):616-21. [PMC free article] [PubMed]
98) Hjalmarson O, Hanson LA, Nilsson LA. IgA deficiency during D-penicillamine treatment. Br
Med J. 1977 Feb 26;1(6060):549. [PMC free article] [PubMed]
99) Vo Ngoc DT, Krist L, van Overveld FJ, Rijkers GT. The long and winding road to IgA
deficiency: causes and consequences. Expert Rev Clin Immunol. 2017 Apr;13(4):371-382.
[PubMed]
100) Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol. 2006
Jan;208(2):270-82. [PubMed]
101) Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and
common variable immunodeficiency (CVID). Clin Exp Immunol. 2000 May;120(2):225-31.
[PMC free article] [PubMed]
102) Swain S, Selmi C, Gershwin ME, Teuber SS. The clinical implications of selective IgA
deficiency. J Transl Autoimmun. 2019 Dec;2:100025. [PMC free article] [PubMed]
103) Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001
Sep;21(5):303-9. [PubMed]
104) Kaplan B, Kopyltsova Y, Khokhar A, Lam F, Bonagura V. Rituximab and immune
deficiency: case series and review of the literature. J Allergy Clin Immunol Pract. 2014 Sep-
Oct;2(5):594-600. [PubMed]
105) Lycke N, Erlandsson L, Ekman L, Schön K, Leanderson T. Lack of J chain inhibits the
transport of gut IgA and abrogates the development of intestinal antitoxic protection. J Immunol.
1999 Jul 15;163(2):913-9. [PubMed]
106) Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin
formation. Scand J Immunol. 2000 Sep;52(3):240-8. [PubMed]
107) Mella MA, Lavrinienko A, Akhi R, Hindström R, Nissinen AE, Wang C, Kullaa A, Salo
T, Auvinen J, Koskimäki JJ, Hörkkö S. Compensatory IgM to the Rescue: Patients with
Selective IgA Deficiency Have Increased Natural IgM Antibodies to MAA-LDL and No
Changes in Oral Microbiota. Immunohorizons. 2021 Apr 23;5(4):170-181. [PubMed]
108) Aghamohammadi A, Abolhassani H, Biglari M, Abolmaali S, Moazzami K,
Tabatabaeiyan M, Asgarian-Omran H, Parvaneh N, Mirahmadian M, Rezaei N. Analysis of
 switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol.
2011;156(4):462-8. [PubMed]
109) Abolhassani H, Aghamohammadi A, Hammarström L. Monogenic mutations associated
with IgA deficiency. Expert Rev Clin Immunol. 2016 Dec;12(12):1321-1335. [PubMed]
110) Giza S, Kotanidou E, Papadopoulou-Alataki E, Antoniou MC, Maggana I, Kyrgios I,
Galli-Tsinopoulou A. Prevalence of selective immunoglobulin A deficiency in Greek children
and adolescents with type 1 diabetes. World J Pediatr. 2016 Nov;12(4):470-476. [PubMed]
111) Gulez N, Karaca NE, Aksu G, Kutukculer N. Increased percentages of autoantibodies in
immunoglobulin A-deficient children do not correlate with clinical manifestations.
Autoimmunity. 2009 Jan;42(1):74-9. [PubMed]
112) Méndez Loayza DLÁ, Arriola Spátola MA, Gonzáles de Campos AL, Montenegro Pucci
C, Olano Gossweiler C. [Prevalence and characteristics of selective IgA deficiency in celiac
patients]. Rev Gastroenterol Peru. 2021 Jan-Mar;41(1):11-15. [PubMed]
113) Qamar N, Fuleihan RL. The hyper IgM syndromes. Clin Rev Allergy Immunol. 2014
Apr;46(2):120-30. [PubMed]
114) Agarwal S, Cunningham-Rundles C. Thymoma and immunodeficiency (Good
syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma
Immunol. 2007 Feb;98(2):185-90. [PMC free article] [PubMed]
115) Sørrig R, Klausen TW, Salomo M, Vangsted AJ, Frølund UC, Andersen KT,
Klostergaard A, Helleberg C, Pedersen RS, Pedersen PT, Helm-Petersen S, Teodorescu EM,
Preiss B, Abildgaard N, Gimsing P., Danish Myeloma Study Group. Immunoparesis in newly
diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival
in the Danish population. PLoS One. 2017;12(12):e0188988. [PMC free article] [PubMed]
116) Ozkan H, Atlihan F, Genel F, Targan S, Gunvar T. IgA and/or IgG subclass deficiency in
children with recurrent respiratory infections and its relationship with chronic pulmonary
damage. J Investig Allergol Clin Immunol. 2005;15(1):69-74. [PubMed]
117) Schussler E, Beasley MB, Maglione PJ. Lung Disease in Primary Antibody Deficiencies.
J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1039-1052. [PMC free article] [PubMed]
118) Ludvigsson JF, Neovius M, Ye W, Hammarström L. IgA deficiency and risk of cancer: a
population-based matched cohort study. J Clin Immunol. 2015 Feb;35(2):182-8. [PubMed]
119) Quiding-Järbrink M, Sundström P, Lundgren A, Hansson M, Bäckström M, Johansson C,
Enarsson K, Hermansson M, Johnsson E, Svennerholm AM. Decreased IgA antibody production
in the stomach of gastric adenocarcinoma patients. Clin Immunol. 2009 Jun;131(3):463-71.
[PubMed]
120) Mathew SK, Anjum F. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL):
Jun 19, 2022. Transfusion Selective IgA Deficiency. [PubMed]
121) Çölkesen F, Kandemir B, Arslan Ş, Çölkesen F, Yıldız E, Korkmaz C, Vatansev H,
Evcen R, Aykan FS, Kılınç M, Aytekin G, Feyzioğlu B, Doğan M, Teke T. Relationship between
Selective IgA Deficiency and COVID-19 Prognosis. Jpn J Infect Dis. 2022 May 24;75(3):228-
233. [PubMed]
122) Quinti I, Mortari EP, Fernandez Salinas A, Milito C, Carsetti R. IgA Antibodies and IgA
Deficiency in SARS-CoV-2 Infection. Front Cell Infect Microbiol. 2021;11:655896. [PMC free
article] [PubMed]